Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: What lessons have we learned? Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • ErbB Receptors
  • Medical Oncology
  • Neoplasms

publication date

  • December 2008

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/978-0-387-73898-7_10

PubMed ID

  • 18593020

Additional Document Info

start page

  • 128

end page

  • 43

volume

  • 610